BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Alisporivir: Phase IIb data

A double-blind, international Phase IIb trial in about 300 previously untreated patients with HCV genotype 1 infection showed that alisporivir plus standard of care (SOC; Pegasys peginterferon alfa-2a and Copegus ribavirin) met the primary endpoint of a...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >